Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01938001
Brief Title: Rituximab Plus Lenalidomide for Patients With Relapsed / Refractory Indolent Non-Hodgkin's Lymphoma (Follicular Lymphoma and Marginal Zone Lymphoma) (AUGMENT)

First Submitted : September 5, 2013
First Submitted that Met QC Criteria : September 9, 2013
First Posted : September 10, 2013 (Estimate)

Results First Submitted : June 21, 2019
Results First Submitted that Met QC Criteria : July 19, 2019
Results First Posted : August 13, 2019

Last Update Submitted that Met QC Criteria : July 19, 2019
Last Update Posted : August 13, 2019